EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration

Jun-Peng Liu, Yi-Fan Jiang, Jin-Wen Liu, Chong-Jiang Tian, Yu-Zhao Lin, Yun-Zhi Yang, Ze-Ke Zhang, Yi-Liang Fang, Bin Huang, Hao Lin iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Jun-Peng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Medical Scientific Research Foundation of Guangdong Province, The National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our study aims to investigate the mechanisms through which Fc receptor‐like A (FCRLA) promotes renal cell carcinoma (RCC) and to examine its significance in relation to tumor immune infiltration. Materials and Methods The correlation between FCRLA and data clinically related to RCC was explored using The Cancer Genome Atlas (TCGA), then validated using Gene Expression Omnibus (GEO) gene chip data. Enrichment and protein–protein interaction (PPI) network analyses were performed for FCRLA and its co‐expressed genes. FCRLA was knocked down in RCC cell lines to evaluate its impact on biological behavior. Then the potential downstream regulators of FCRLA were determined by western blotting, and rescue experiments were performed for verification. The relevance between FCRLA and various immune cells was analyzed through GSEA, TIMER, and GEPIA tools. TIDE and ESTIMATE algorithms were used to predict the effect of FCRLA in immunotherapy.

Results

Fc receptor‐like A was associated with clinical and T stages and could predict the M stage (AUC = 0.692) and 1–3‐ and 5‐year survival rates (AUC = 0.823, 0.834, and 0.862) of RCC patients. Higher expression of FCLRA predicted an unfavorable overall survival (OS) in TCGA‐RCC and GSE167573 datasets ( p = 0.03, p = 0.04). FCRLA promoted the malignant biological behavior of RCC cells through the pERK1/2/‐MMP2 pathway and was associated with tumor immune microenvironment in RCC.

Conclusion

Fc receptor‐like A is positively correlated with poor outcomes in RCC patients and plays an oncogenic role in RCC through the pERK1/2‐MMP2 pathway. Patients with RCC might benefit from immunotherapy targeting FCRLA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsFemaleHumansMaleBiomarkers, TumorCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticLymphocytes, Tumor-InfiltratingMatrix Metalloproteinase 2PrognosisProtein Interaction MapsReceptors, FcTumor Microenvironment

Stichwörter der Autor:innen

FCRLAMMP2immune infiltrationpERK1/2renal cell carcinoma

Substanzen

Biomarkers, TumorMatrix Metalloproteinase 2Receptors, FcFCRLA protein, human

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Hao Lin

Förderung

  • the Medical Scientific Research Foundation of Guangdong Province
  • The National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Liu, J. P., Jiang, Y. F., Liu, J. W., Tian, C. J., Lin, Y. Z., Yang, Y. Z., Zhang, Z. K., Fang, Y. L., Huang, B., & Lin, H. (2024). Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration. Cancer Medicine. https://doi.org/10.1002/cam4.70072

Vancouver

Liu JP, Jiang YF, Liu JW, Tian CJ, Lin YZ, Yang YZ, et al. Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration. Cancer Medicine. 2024. doi:10.1002/cam4.70072

BibTeX
@article{Liu2024,
  author = {Liu, Jun-Peng and Jiang, Yi-Fan and Liu, Jin-Wen and Tian, Chong-Jiang and Lin, Yu-Zhao and Yang, Yun-Zhi and Zhang, Ze-Ke and Fang, Yi-Liang and Huang, Bin and Lin, Hao},
  title = {Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70072}
}
Kostenlos starten →